<b>Nervous system - Systema nervosum</b> | Interpretable prognosis for susceptibility to active anti-cancer molecular forms, based on amides/carboxylic acids - hydrolysis derivatives of natural nitrile glycosides, of transcriptome cell lines inherent in tumors

<p dir="ltr">excerpt from an edition:</p><p dir="ltr"><b>A T L A S</b> - Interpretable prognosis for susceptibility to active anti-cancer molecular forms, based on amides/carboxylic acids - hydrolysis derivatives of natural nitrile glycosides, of transcriptome cell lines inherent in tumors /Second supplemented edition/ - DOI: <a href="http://doi.org/10.5281/zenodo.13777292" target="_blank">10.5281/zenodo.13777292</a> | ISBN: 978-619-91534-6-8</p><p>--------------</p><p dir="ltr">From the data on the interpretable prognosis of sensitivity to active anti-cancer molecular forms (<i>p.10 </i>form the ATLAS) of transcriptome cell lines inherent in tumors in the <b><i>Nervous system </i></b>(<b><i>a.</i></b> & <b><i>b.</i></b>), it is concluded that:</p><p dir="ltr"><b>- some of the main potential medicines:</b></p><p dir="ltr"><i>(2S,3S)-2-hydroxy-4-methoxy-1-methyl-6-oxo-3-(((2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,2,3,6-tetrahydropyridine-3-carboxamide</i> and <i>.../carboxylic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(2S,3S)-2,3-dihydroxy-4-methoxy-1-methyl-6-oxo-1,2,3,6-tetrahydropyridine-3-carboxamide</i> and <i>.../carboxylic acid </i> ,</p><p dir="ltr"><i>(R)-2-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)butanamide</i> and <i>.../butanoic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(R)-2-hydroxy-2-methylbutanamide</i> and <i>.../butanoic acid</i> ,</p><p dir="ltr"><i>(R)-3-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)but-3-enamide</i> and<i> .../enoic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(R)-2-hydroxy-3-methylbut-3-enamide</i> and <i>.../enoic acid</i> ,</p><p dir="ltr"><i>(Z)-2-((2S,3R,4S,6R)-2,3-dihydroxy-4-methoxy-6-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)cyclohexylidene)acetamide</i> and <i>.../acetic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(E)-2-((2S,3R,4S,6R)-2,3,6-trihydroxy-4-methoxycyclohexylidene)acetamide</i> and <i>.../acetic acid</i> ,</p><p dir="ltr"><i>(E)-2-carbamoyl-4-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)but-2-en-1-yl 4-hydroxy-3,5-dimethoxybenzoate </i>and <i>(E)-2-(((4-hydroxy-3,5-dimethoxybenzoyl)oxy)methyl)-4-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)but-2-enoic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(E)-2-carbamoyl-4-hydroxybut-2-en-1-yl 4-hydroxy-3,5-dimethoxybenzoate</i> and <i>(E)-4-hydroxy-2-(((4-hydroxy-3,5-dimethoxybenzoyl)oxy)methyl)but-2-enoic acid</i> ,</p><p dir="ltr">the rest ACCF can be found in the file and the ATLAS ;</p><p dir="ltr"><b>- certain medicines for duplication of treatment and/or replacement for medical reasons:</b></p><p dir="ltr"><i>(R)-2-phenyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)acetamide</i> and <i>.../acetic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(R)-2-hydroxy-2-phenylacetamide</i> and <i>.../acetic acid </i>,</p><p dir="ltr"><i>(2R,3R,4S,5R,6R)-2-(((Z)-4-amino-2-methyl-4-oxobut-2-en-1-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl acetate</i> and <i>(Z)-4-(((2R,3R,4S,5R,6R)-4-acetoxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-methylbut-2-enoic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(Z)-4-hydroxy-3-methylbut-2-enamide</i> and <i>.../enoic acid </i> ,</p><p dir="ltr"><i>(Z)-2-(hydroxymethyl)-4-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)but-2-enamide</i> and <i>.../enoic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(Z)-4-hydroxy-2-(hydroxymethyl)but-2-enamide</i> and <i>.../enoic acid</i> ,</p><p dir="ltr">the rest ACCF can be found in the file and the ATLAS.</p><p>-------</p><p dir="ltr"><b><u>Important! Do not forget to comply with the current clinical control.</u></b></p><p dir="ltr">The idea timeline: <a href="https://anti-cancer.eu/" target="_blank">anti-cancer.eu</a></p><p><br></p>